EGLN1 and neoplasm: It also inhibits prolyl hydroxylase domain-containing protein 2 (PHD2), leading to stabilization of HIF-1α, while modifying histones to regulate gene expression, thereby reinforcing tumor adaptability under metabolic stress [41].